nodes	percent_of_prediction	percent_of_DWPC	metapath
Temsirolimus—CYP3A4—Temozolomide—malignant glioma	0.0502	1	CbGbCtD
Temsirolimus—Alveolitis—Temozolomide—malignant glioma	0.027	0.0682	CcSEcCtD
Temsirolimus—Pneumocystis jirovecii pneumonia—Temozolomide—malignant glioma	0.027	0.0682	CcSEcCtD
Temsirolimus—Wound infection—Temozolomide—malignant glioma	0.0206	0.0521	CcSEcCtD
Temsirolimus—Sirolimus—FGF2—malignant glioma	0.0112	1	CrCbGaD
Temsirolimus—Haemorrhage intracranial—Temozolomide—malignant glioma	0.00826	0.0208	CcSEcCtD
Temsirolimus—Impaired healing—Carmustine—malignant glioma	0.0081	0.0205	CcSEcCtD
Temsirolimus—Pulmonary fibrosis—Carmustine—malignant glioma	0.00797	0.0201	CcSEcCtD
Temsirolimus—Pulmonary fibrosis—Temozolomide—malignant glioma	0.0077	0.0194	CcSEcCtD
Temsirolimus—MTOR—blood vessel—malignant glioma	0.00741	0.12	CbGeAlD
Temsirolimus—Interstitial pneumonia—Temozolomide—malignant glioma	0.00701	0.0177	CcSEcCtD
Temsirolimus—Lymphopenia—Temozolomide—malignant glioma	0.00662	0.0167	CcSEcCtD
Temsirolimus—Febrile neutropenia—Carmustine—malignant glioma	0.00583	0.0147	CcSEcCtD
Temsirolimus—Febrile neutropenia—Temozolomide—malignant glioma	0.00563	0.0142	CcSEcCtD
Temsirolimus—Deep vein thrombosis—Temozolomide—malignant glioma	0.00557	0.0141	CcSEcCtD
Temsirolimus—Interstitial lung disease—Carmustine—malignant glioma	0.00495	0.0125	CcSEcCtD
Temsirolimus—Lung disorder—Temozolomide—malignant glioma	0.00479	0.0121	CcSEcCtD
Temsirolimus—Interstitial lung disease—Temozolomide—malignant glioma	0.00479	0.0121	CcSEcCtD
Temsirolimus—Herpes zoster—Temozolomide—malignant glioma	0.0045	0.0114	CcSEcCtD
Temsirolimus—Abscess—Carmustine—malignant glioma	0.00443	0.0112	CcSEcCtD
Temsirolimus—MTOR—embryo—malignant glioma	0.00442	0.0715	CbGeAlD
Temsirolimus—Petechiae—Temozolomide—malignant glioma	0.00412	0.0104	CcSEcCtD
Temsirolimus—MTOR—brainstem—malignant glioma	0.00405	0.0655	CbGeAlD
Temsirolimus—Extravasation—Carmustine—malignant glioma	0.00402	0.0101	CcSEcCtD
Temsirolimus—MTOR—retina—malignant glioma	0.00391	0.0632	CbGeAlD
Temsirolimus—Viral infection—Temozolomide—malignant glioma	0.00375	0.00947	CcSEcCtD
Temsirolimus—Herpes simplex—Temozolomide—malignant glioma	0.00368	0.00928	CcSEcCtD
Temsirolimus—MTOR—telencephalon—malignant glioma	0.0036	0.0581	CbGeAlD
Temsirolimus—FKBP1A—retina—malignant glioma	0.00352	0.0568	CbGeAlD
Temsirolimus—Pulmonary embolism—Carmustine—malignant glioma	0.00351	0.00885	CcSEcCtD
Temsirolimus—Pulmonary embolism—Temozolomide—malignant glioma	0.00339	0.00855	CcSEcCtD
Temsirolimus—Phosphatase alkaline increased—Temozolomide—malignant glioma	0.00339	0.00855	CcSEcCtD
Temsirolimus—Candida infection—Carmustine—malignant glioma	0.00335	0.00845	CcSEcCtD
Temsirolimus—FKBP1A—telencephalon—malignant glioma	0.00323	0.0523	CbGeAlD
Temsirolimus—Candida infection—Temozolomide—malignant glioma	0.00323	0.00817	CcSEcCtD
Temsirolimus—Sepsis—Carmustine—malignant glioma	0.00304	0.00768	CcSEcCtD
Temsirolimus—Thrombophlebitis—Carmustine—malignant glioma	0.00294	0.00742	CcSEcCtD
Temsirolimus—Diabetes mellitus—Carmustine—malignant glioma	0.00293	0.00739	CcSEcCtD
Temsirolimus—Swelling—Carmustine—malignant glioma	0.00288	0.00728	CcSEcCtD
Temsirolimus—Thrombophlebitis—Temozolomide—malignant glioma	0.00284	0.00717	CcSEcCtD
Temsirolimus—Blood alkaline phosphatase increased—Temozolomide—malignant glioma	0.00283	0.00714	CcSEcCtD
Temsirolimus—Dermatitis exfoliative—Temozolomide—malignant glioma	0.00261	0.00658	CcSEcCtD
Temsirolimus—Gastrointestinal haemorrhage—Carmustine—malignant glioma	0.00254	0.00642	CcSEcCtD
Temsirolimus—FKBP1A—medulla oblongata—malignant glioma	0.00254	0.0411	CbGeAlD
Temsirolimus—MTOR—spinal cord—malignant glioma	0.00252	0.0407	CbGeAlD
Temsirolimus—Face oedema—Carmustine—malignant glioma	0.00246	0.0062	CcSEcCtD
Temsirolimus—Face oedema—Temozolomide—malignant glioma	0.00237	0.00599	CcSEcCtD
Temsirolimus—FKBP1A—midbrain—malignant glioma	0.00232	0.0376	CbGeAlD
Temsirolimus—Hypokalaemia—Carmustine—malignant glioma	0.00232	0.00585	CcSEcCtD
Temsirolimus—Dehydration—Temozolomide—malignant glioma	0.00229	0.00577	CcSEcCtD
Temsirolimus—FKBP1A—spinal cord—malignant glioma	0.00227	0.0366	CbGeAlD
Temsirolimus—Dry skin—Temozolomide—malignant glioma	0.00225	0.00569	CcSEcCtD
Temsirolimus—Hypokalaemia—Temozolomide—malignant glioma	0.00224	0.00565	CcSEcCtD
Temsirolimus—Aspartate aminotransferase increased—Temozolomide—malignant glioma	0.00221	0.00559	CcSEcCtD
Temsirolimus—Dysphagia—Carmustine—malignant glioma	0.0022	0.00555	CcSEcCtD
Temsirolimus—Alanine aminotransferase increased—Temozolomide—malignant glioma	0.00217	0.00548	CcSEcCtD
Temsirolimus—Abdominal distension—Temozolomide—malignant glioma	0.00214	0.0054	CcSEcCtD
Temsirolimus—Dysphagia—Temozolomide—malignant glioma	0.00213	0.00537	CcSEcCtD
Temsirolimus—Neutropenia—Carmustine—malignant glioma	0.00206	0.00519	CcSEcCtD
Temsirolimus—MTOR—central nervous system—malignant glioma	0.00204	0.033	CbGeAlD
Temsirolimus—Bronchitis—Temozolomide—malignant glioma	0.00204	0.00516	CcSEcCtD
Temsirolimus—MTOR—cerebellum—malignant glioma	0.002	0.0323	CbGeAlD
Temsirolimus—Dysuria—Temozolomide—malignant glioma	0.00199	0.00502	CcSEcCtD
Temsirolimus—Neutropenia—Temozolomide—malignant glioma	0.00199	0.00502	CcSEcCtD
Temsirolimus—Hyperglycaemia—Carmustine—malignant glioma	0.00198	0.00501	CcSEcCtD
Temsirolimus—Upper respiratory tract infection—Temozolomide—malignant glioma	0.00198	0.00499	CcSEcCtD
Temsirolimus—Pneumonia—Carmustine—malignant glioma	0.00197	0.00498	CcSEcCtD
Temsirolimus—Pollakiuria—Temozolomide—malignant glioma	0.00196	0.00496	CcSEcCtD
Temsirolimus—Depression—Carmustine—malignant glioma	0.00196	0.00494	CcSEcCtD
Temsirolimus—Renal failure—Carmustine—malignant glioma	0.00193	0.00487	CcSEcCtD
Temsirolimus—Weight decreased—Temozolomide—malignant glioma	0.00192	0.00485	CcSEcCtD
Temsirolimus—Hyperglycaemia—Temozolomide—malignant glioma	0.00192	0.00484	CcSEcCtD
Temsirolimus—Stomatitis—Carmustine—malignant glioma	0.00191	0.00483	CcSEcCtD
Temsirolimus—Urinary tract infection—Carmustine—malignant glioma	0.00191	0.00481	CcSEcCtD
Temsirolimus—Pneumonia—Temozolomide—malignant glioma	0.00191	0.00481	CcSEcCtD
Temsirolimus—Infestation NOS—Temozolomide—malignant glioma	0.00189	0.00478	CcSEcCtD
Temsirolimus—Infestation—Temozolomide—malignant glioma	0.00189	0.00478	CcSEcCtD
Temsirolimus—Depression—Temozolomide—malignant glioma	0.00189	0.00477	CcSEcCtD
Temsirolimus—Stevens-Johnson syndrome—Temozolomide—malignant glioma	0.00188	0.00474	CcSEcCtD
Temsirolimus—Stomatitis—Temozolomide—malignant glioma	0.00185	0.00466	CcSEcCtD
Temsirolimus—Urinary tract infection—Temozolomide—malignant glioma	0.00184	0.00465	CcSEcCtD
Temsirolimus—FKBP1A—central nervous system—malignant glioma	0.00184	0.0297	CbGeAlD
Temsirolimus—FKBP1A—cerebellum—malignant glioma	0.0018	0.0291	CbGeAlD
Temsirolimus—Sinusitis—Temozolomide—malignant glioma	0.00178	0.00449	CcSEcCtD
Temsirolimus—Oedema peripheral—Carmustine—malignant glioma	0.00173	0.00438	CcSEcCtD
Temsirolimus—Connective tissue disorder—Carmustine—malignant glioma	0.00173	0.00437	CcSEcCtD
Temsirolimus—Pharyngitis—Temozolomide—malignant glioma	0.00169	0.00426	CcSEcCtD
Temsirolimus—Urinary tract disorder—Temozolomide—malignant glioma	0.00168	0.00424	CcSEcCtD
Temsirolimus—Oedema peripheral—Temozolomide—malignant glioma	0.00168	0.00423	CcSEcCtD
Temsirolimus—Connective tissue disorder—Temozolomide—malignant glioma	0.00167	0.00422	CcSEcCtD
Temsirolimus—Urethral disorder—Temozolomide—malignant glioma	0.00167	0.00421	CcSEcCtD
Temsirolimus—Eye disorder—Carmustine—malignant glioma	0.00164	0.00415	CcSEcCtD
Temsirolimus—MTOR—brain—malignant glioma	0.00162	0.0262	CbGeAlD
Temsirolimus—Erythema multiforme—Temozolomide—malignant glioma	0.00161	0.00406	CcSEcCtD
Temsirolimus—Eye disorder—Temozolomide—malignant glioma	0.00159	0.00401	CcSEcCtD
Temsirolimus—Cardiac disorder—Temozolomide—malignant glioma	0.00158	0.00399	CcSEcCtD
Temsirolimus—Angiopathy—Temozolomide—malignant glioma	0.00154	0.0039	CcSEcCtD
Temsirolimus—ABCB1—blood vessel—malignant glioma	0.00154	0.0249	CbGeAlD
Temsirolimus—Mental disorder—Carmustine—malignant glioma	0.00154	0.00389	CcSEcCtD
Temsirolimus—Immune system disorder—Temozolomide—malignant glioma	0.00154	0.00388	CcSEcCtD
Temsirolimus—Mediastinal disorder—Temozolomide—malignant glioma	0.00153	0.00387	CcSEcCtD
Temsirolimus—Erythema—Carmustine—malignant glioma	0.00153	0.00387	CcSEcCtD
Temsirolimus—Malnutrition—Carmustine—malignant glioma	0.00153	0.00387	CcSEcCtD
Temsirolimus—Chills—Temozolomide—malignant glioma	0.00153	0.00385	CcSEcCtD
Temsirolimus—Mental disorder—Temozolomide—malignant glioma	0.00149	0.00376	CcSEcCtD
Temsirolimus—Back pain—Carmustine—malignant glioma	0.00148	0.00374	CcSEcCtD
Temsirolimus—Erythema—Temozolomide—malignant glioma	0.00148	0.00374	CcSEcCtD
Temsirolimus—Malnutrition—Temozolomide—malignant glioma	0.00148	0.00374	CcSEcCtD
Temsirolimus—FKBP1A—brain—malignant glioma	0.00146	0.0236	CbGeAlD
Temsirolimus—Dysgeusia—Temozolomide—malignant glioma	0.00145	0.00366	CcSEcCtD
Temsirolimus—Back pain—Temozolomide—malignant glioma	0.00143	0.00362	CcSEcCtD
Temsirolimus—Anaemia—Carmustine—malignant glioma	0.00142	0.00358	CcSEcCtD
Temsirolimus—Leukopenia—Carmustine—malignant glioma	0.00137	0.00346	CcSEcCtD
Temsirolimus—Anaemia—Temozolomide—malignant glioma	0.00137	0.00346	CcSEcCtD
Temsirolimus—Angioedema—Temozolomide—malignant glioma	0.00135	0.00342	CcSEcCtD
Temsirolimus—Convulsion—Carmustine—malignant glioma	0.00133	0.00335	CcSEcCtD
Temsirolimus—Leukopenia—Temozolomide—malignant glioma	0.00133	0.00335	CcSEcCtD
Temsirolimus—Hypertension—Carmustine—malignant glioma	0.00132	0.00334	CcSEcCtD
Temsirolimus—Chest pain—Carmustine—malignant glioma	0.0013	0.00329	CcSEcCtD
Temsirolimus—Myalgia—Carmustine—malignant glioma	0.0013	0.00329	CcSEcCtD
Temsirolimus—Anxiety—Carmustine—malignant glioma	0.0013	0.00328	CcSEcCtD
Temsirolimus—Cough—Temozolomide—malignant glioma	0.00129	0.00326	CcSEcCtD
Temsirolimus—Convulsion—Temozolomide—malignant glioma	0.00128	0.00324	CcSEcCtD
Temsirolimus—Hypertension—Temozolomide—malignant glioma	0.00128	0.00323	CcSEcCtD
Temsirolimus—Myalgia—Temozolomide—malignant glioma	0.00126	0.00318	CcSEcCtD
Temsirolimus—Arthralgia—Temozolomide—malignant glioma	0.00126	0.00318	CcSEcCtD
Temsirolimus—Anxiety—Temozolomide—malignant glioma	0.00126	0.00317	CcSEcCtD
Temsirolimus—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—malignant glioma	0.00125	0.00316	CcSEcCtD
Temsirolimus—Oedema—Carmustine—malignant glioma	0.00125	0.00316	CcSEcCtD
Temsirolimus—Infection—Carmustine—malignant glioma	0.00124	0.00314	CcSEcCtD
Temsirolimus—Thrombocytopenia—Carmustine—malignant glioma	0.00122	0.00309	CcSEcCtD
Temsirolimus—Anaphylactic shock—Temozolomide—malignant glioma	0.00121	0.00305	CcSEcCtD
Temsirolimus—Oedema—Temozolomide—malignant glioma	0.00121	0.00305	CcSEcCtD
Temsirolimus—Infection—Temozolomide—malignant glioma	0.0012	0.00303	CcSEcCtD
Temsirolimus—Anorexia—Carmustine—malignant glioma	0.00119	0.00301	CcSEcCtD
Temsirolimus—Nervous system disorder—Temozolomide—malignant glioma	0.00119	0.00299	CcSEcCtD
Temsirolimus—Thrombocytopenia—Temozolomide—malignant glioma	0.00118	0.00299	CcSEcCtD
Temsirolimus—Skin disorder—Temozolomide—malignant glioma	0.00117	0.00296	CcSEcCtD
Temsirolimus—CYP2D6—brainstem—malignant glioma	0.00117	0.0189	CbGeAlD
Temsirolimus—Anorexia—Temozolomide—malignant glioma	0.00115	0.00291	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Carmustine—malignant glioma	0.00114	0.00288	CcSEcCtD
Temsirolimus—Insomnia—Carmustine—malignant glioma	0.00113	0.00286	CcSEcCtD
Temsirolimus—Dyspnoea—Carmustine—malignant glioma	0.00111	0.00282	CcSEcCtD
Temsirolimus—Somnolence—Carmustine—malignant glioma	0.00111	0.00281	CcSEcCtD
Temsirolimus—Musculoskeletal discomfort—Temozolomide—malignant glioma	0.0011	0.00278	CcSEcCtD
Temsirolimus—Insomnia—Temozolomide—malignant glioma	0.00109	0.00276	CcSEcCtD
Temsirolimus—Decreased appetite—Carmustine—malignant glioma	0.00109	0.00275	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Carmustine—malignant glioma	0.00108	0.00273	CcSEcCtD
Temsirolimus—Dyspnoea—Temozolomide—malignant glioma	0.00108	0.00272	CcSEcCtD
Temsirolimus—Somnolence—Temozolomide—malignant glioma	0.00107	0.00271	CcSEcCtD
Temsirolimus—Constipation—Carmustine—malignant glioma	0.00107	0.0027	CcSEcCtD
Temsirolimus—Pain—Carmustine—malignant glioma	0.00107	0.0027	CcSEcCtD
Temsirolimus—Decreased appetite—Temozolomide—malignant glioma	0.00105	0.00265	CcSEcCtD
Temsirolimus—Gastrointestinal disorder—Temozolomide—malignant glioma	0.00104	0.00263	CcSEcCtD
Temsirolimus—Fatigue—Temozolomide—malignant glioma	0.00104	0.00263	CcSEcCtD
Temsirolimus—CYP2D6—telencephalon—malignant glioma	0.00104	0.0168	CbGeAlD
Temsirolimus—Pain—Temozolomide—malignant glioma	0.00103	0.00261	CcSEcCtD
Temsirolimus—Constipation—Temozolomide—malignant glioma	0.00103	0.00261	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Carmustine—malignant glioma	0.00102	0.00258	CcSEcCtD
Temsirolimus—Body temperature increased—Carmustine—malignant glioma	0.000989	0.0025	CcSEcCtD
Temsirolimus—Abdominal pain—Carmustine—malignant glioma	0.000989	0.0025	CcSEcCtD
Temsirolimus—Gastrointestinal pain—Temozolomide—malignant glioma	0.000988	0.0025	CcSEcCtD
Temsirolimus—Body temperature increased—Temozolomide—malignant glioma	0.000955	0.00241	CcSEcCtD
Temsirolimus—Abdominal pain—Temozolomide—malignant glioma	0.000955	0.00241	CcSEcCtD
Temsirolimus—Hypersensitivity—Carmustine—malignant glioma	0.000921	0.00233	CcSEcCtD
Temsirolimus—ABCB1—embryo—malignant glioma	0.00092	0.0149	CbGeAlD
Temsirolimus—Asthenia—Carmustine—malignant glioma	0.000897	0.00227	CcSEcCtD
Temsirolimus—Hypersensitivity—Temozolomide—malignant glioma	0.00089	0.00225	CcSEcCtD
Temsirolimus—Asthenia—Temozolomide—malignant glioma	0.000867	0.00219	CcSEcCtD
Temsirolimus—Diarrhoea—Carmustine—malignant glioma	0.000856	0.00216	CcSEcCtD
Temsirolimus—Pruritus—Temozolomide—malignant glioma	0.000855	0.00216	CcSEcCtD
Temsirolimus—Dizziness—Carmustine—malignant glioma	0.000827	0.00209	CcSEcCtD
Temsirolimus—Diarrhoea—Temozolomide—malignant glioma	0.000827	0.00209	CcSEcCtD
Temsirolimus—ABCB1—retina—malignant glioma	0.000813	0.0131	CbGeAlD
Temsirolimus—Dizziness—Temozolomide—malignant glioma	0.000799	0.00202	CcSEcCtD
Temsirolimus—Vomiting—Carmustine—malignant glioma	0.000795	0.00201	CcSEcCtD
Temsirolimus—Rash—Carmustine—malignant glioma	0.000788	0.00199	CcSEcCtD
Temsirolimus—Dermatitis—Carmustine—malignant glioma	0.000788	0.00199	CcSEcCtD
Temsirolimus—Headache—Carmustine—malignant glioma	0.000783	0.00198	CcSEcCtD
Temsirolimus—Vomiting—Temozolomide—malignant glioma	0.000768	0.00194	CcSEcCtD
Temsirolimus—Rash—Temozolomide—malignant glioma	0.000762	0.00192	CcSEcCtD
Temsirolimus—Dermatitis—Temozolomide—malignant glioma	0.000761	0.00192	CcSEcCtD
Temsirolimus—Headache—Temozolomide—malignant glioma	0.000757	0.00191	CcSEcCtD
Temsirolimus—ABCB1—telencephalon—malignant glioma	0.000748	0.0121	CbGeAlD
Temsirolimus—Nausea—Carmustine—malignant glioma	0.000743	0.00188	CcSEcCtD
Temsirolimus—Nausea—Temozolomide—malignant glioma	0.000718	0.00181	CcSEcCtD
Temsirolimus—CYP3A4—central nervous system—malignant glioma	0.000601	0.00971	CbGeAlD
Temsirolimus—CYP2D6—central nervous system—malignant glioma	0.000591	0.00956	CbGeAlD
Temsirolimus—ABCB1—medulla oblongata—malignant glioma	0.000588	0.0095	CbGeAlD
Temsirolimus—CYP2D6—cerebellum—malignant glioma	0.000578	0.00934	CbGeAlD
Temsirolimus—ABCB1—midbrain—malignant glioma	0.000537	0.00869	CbGeAlD
Temsirolimus—ABCB1—spinal cord—malignant glioma	0.000524	0.00848	CbGeAlD
Temsirolimus—CYP2D6—brain—malignant glioma	0.000469	0.00759	CbGeAlD
Temsirolimus—ABCB1—central nervous system—malignant glioma	0.000425	0.00688	CbGeAlD
Temsirolimus—ABCB1—cerebellum—malignant glioma	0.000416	0.00672	CbGeAlD
Temsirolimus—ABCB1—brain—malignant glioma	0.000338	0.00546	CbGeAlD
Temsirolimus—FKBP1A—Signaling Pathways—NOTCH1—malignant glioma	5.66e-05	0.000118	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FBXW7—malignant glioma	5.64e-05	0.000117	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PDGFB—malignant glioma	5.57e-05	0.000116	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CYP2C18—malignant glioma	5.55e-05	0.000115	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FGFR1—malignant glioma	5.54e-05	0.000115	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CD80—malignant glioma	5.54e-05	0.000115	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—APC—malignant glioma	5.53e-05	0.000115	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PIK3CG—malignant glioma	5.53e-05	0.000115	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—BDKRB2—malignant glioma	5.53e-05	0.000115	CbGpPWpGaD
Temsirolimus—MTOR—Signaling by NGF—AKT1—malignant glioma	5.53e-05	0.000115	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—PTEN—malignant glioma	5.47e-05	0.000114	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EGF—malignant glioma	5.47e-05	0.000114	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PTPN11—malignant glioma	5.43e-05	0.000113	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—BCHE—malignant glioma	5.41e-05	0.000112	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—SLC5A5—malignant glioma	5.34e-05	0.000111	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HLA-A—malignant glioma	5.27e-05	0.00011	CbGpPWpGaD
Temsirolimus—MTOR—Disease—TERT—malignant glioma	5.27e-05	0.00011	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—PTEN—malignant glioma	5.25e-05	0.000109	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PTEN—malignant glioma	5.23e-05	0.000109	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—BRAF—malignant glioma	5.2e-05	0.000108	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—malignant glioma	5.15e-05	0.000107	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PDGFB—malignant glioma	5.15e-05	0.000107	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NOTCH2—malignant glioma	5.14e-05	0.000107	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—IDH2—malignant glioma	5.14e-05	0.000107	CbGpPWpGaD
Temsirolimus—MTOR—Disease—FGFR1—malignant glioma	5.12e-05	0.000106	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—AKT2—malignant glioma	5.06e-05	0.000105	CbGpPWpGaD
Temsirolimus—MTOR—Disease—HIF1A—malignant glioma	5.04e-05	0.000105	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—KNG1—malignant glioma	5.03e-05	0.000105	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—BAD—malignant glioma	4.97e-05	0.000103	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—COX8A—malignant glioma	4.91e-05	0.000102	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CAV1—malignant glioma	4.88e-05	0.000101	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PIK3CD—malignant glioma	4.86e-05	0.000101	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—IDH2—malignant glioma	4.84e-05	0.000101	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP2B6—malignant glioma	4.83e-05	0.0001	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—CD80—malignant glioma	4.82e-05	0.0001	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NTRK1—malignant glioma	4.79e-05	9.97e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—EGF—malignant glioma	4.76e-05	9.89e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—malignant glioma	4.74e-05	9.86e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PTPN11—malignant glioma	4.73e-05	9.83e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—STAT3—malignant glioma	4.68e-05	9.73e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—FGF2—malignant glioma	4.66e-05	9.68e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—malignant glioma	4.63e-05	9.64e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—BAD—malignant glioma	4.59e-05	9.54e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP2B6—malignant glioma	4.55e-05	9.46e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—NOTCH1—malignant glioma	4.54e-05	9.45e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTT1—malignant glioma	4.49e-05	9.33e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP3—malignant glioma	4.46e-05	9.27e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—CD80—malignant glioma	4.45e-05	9.26e-05	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—EGFR—malignant glioma	4.45e-05	9.25e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—APC—malignant glioma	4.44e-05	9.24e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CDKN2B—malignant glioma	4.42e-05	9.19e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—IDH1—malignant glioma	4.42e-05	9.19e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—malignant glioma	4.41e-05	9.18e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—AKT2—malignant glioma	4.4e-05	9.16e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—EGF—malignant glioma	4.39e-05	9.13e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—malignant glioma	4.38e-05	9.11e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTPN11—malignant glioma	4.36e-05	9.08e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MDM2—malignant glioma	4.36e-05	9.06e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—MYC—malignant glioma	4.35e-05	9.04e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—RAF1—malignant glioma	4.34e-05	9.03e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—GSTP1—malignant glioma	4.3e-05	8.95e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—ERBB2—malignant glioma	4.29e-05	8.93e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PTK2—malignant glioma	4.29e-05	8.92e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SPHK1—malignant glioma	4.27e-05	8.89e-05	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—EGFR—malignant glioma	4.27e-05	8.88e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—EGFR—malignant glioma	4.25e-05	8.84e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PIK3CB—malignant glioma	4.24e-05	8.82e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PIK3CD—malignant glioma	4.23e-05	8.8e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HES1—malignant glioma	4.21e-05	8.76e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTGS1—malignant glioma	4.2e-05	8.75e-05	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—KRAS—malignant glioma	4.2e-05	8.74e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NCOR1—malignant glioma	4.19e-05	8.71e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CAT—malignant glioma	4.19e-05	8.71e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CYP2C18—malignant glioma	4.19e-05	8.71e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—BRAF—malignant glioma	4.18e-05	8.68e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—ASMT—malignant glioma	4.18e-05	8.68e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—IDH1—malignant glioma	4.16e-05	8.66e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CXCL8—malignant glioma	4.07e-05	8.47e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—AKT2—malignant glioma	4.06e-05	8.45e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—FGF2—malignant glioma	4.05e-05	8.42e-05	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—KRAS—malignant glioma	4.03e-05	8.39e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SPHK1—malignant glioma	4.03e-05	8.38e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—malignant glioma	4.02e-05	8.37e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—KRAS—malignant glioma	4.02e-05	8.35e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PDGFRA—malignant glioma	4.01e-05	8.34e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—NCOR1—malignant glioma	3.95e-05	8.22e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CYP2C18—malignant glioma	3.95e-05	8.21e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—BCAN—malignant glioma	3.93e-05	8.17e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—BCHE—malignant glioma	3.91e-05	8.13e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PIK3CD—malignant glioma	3.9e-05	8.12e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—CASP3—malignant glioma	3.9e-05	8.11e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—SPP1—malignant glioma	3.89e-05	8.1e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—IL2—malignant glioma	3.89e-05	8.1e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—malignant glioma	3.89e-05	8.09e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—SLC5A5—malignant glioma	3.86e-05	8.03e-05	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—PIK3CA—malignant glioma	3.86e-05	8.03e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—BCL2—malignant glioma	3.85e-05	8e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IFNG—malignant glioma	3.81e-05	7.92e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—MDM2—malignant glioma	3.79e-05	7.88e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—RAF1—malignant glioma	3.78e-05	7.85e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—FGF2—malignant glioma	3.74e-05	7.78e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—ERBB2—malignant glioma	3.74e-05	7.77e-05	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—PIK3CA—malignant glioma	3.71e-05	7.71e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TERT—malignant glioma	3.69e-05	7.68e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—PIK3CA—malignant glioma	3.69e-05	7.67e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PIK3CB—malignant glioma	3.69e-05	7.67e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MMP9—malignant glioma	3.68e-05	7.66e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PTEN—malignant glioma	3.66e-05	7.62e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PDGFB—malignant glioma	3.6e-05	7.5e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FGFR1—malignant glioma	3.58e-05	7.46e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—HIF1A—malignant glioma	3.53e-05	7.34e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MDM2—malignant glioma	3.5e-05	7.28e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—RAF1—malignant glioma	3.49e-05	7.25e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—ERBB2—malignant glioma	3.45e-05	7.17e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CAV1—malignant glioma	3.41e-05	7.1e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PIK3CB—malignant glioma	3.4e-05	7.08e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL1B—malignant glioma	3.4e-05	7.07e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTT1—malignant glioma	3.39e-05	7.04e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—IL2—malignant glioma	3.39e-05	7.04e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—KDR—malignant glioma	3.38e-05	7.02e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTGS2—malignant glioma	3.37e-05	7.01e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—VEGFA—malignant glioma	3.31e-05	6.88e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—malignant glioma	3.29e-05	6.84e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—STAT3—malignant glioma	3.28e-05	6.81e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—F2—malignant glioma	3.25e-05	6.76e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FN1—malignant glioma	3.25e-05	6.76e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—CAV1—malignant glioma	3.22e-05	6.7e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—BAD—malignant glioma	3.21e-05	6.68e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTT1—malignant glioma	3.19e-05	6.64e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PTEN—malignant glioma	3.19e-05	6.63e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—NOTCH1—malignant glioma	3.18e-05	6.62e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTGS1—malignant glioma	3.17e-05	6.6e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—IDH2—malignant glioma	3.16e-05	6.58e-05	CbGpPWpGaD
Temsirolimus—MTOR—Innate Immune System—AKT1—malignant glioma	3.15e-05	6.56e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CD80—malignant glioma	3.12e-05	6.48e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PIK3CG—malignant glioma	3.11e-05	6.47e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—APC—malignant glioma	3.11e-05	6.47e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—GSTP1—malignant glioma	3.11e-05	6.47e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EGF—malignant glioma	3.07e-05	6.4e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PTPN11—malignant glioma	3.06e-05	6.36e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—MYC—malignant glioma	3.04e-05	6.33e-05	CbGpPWpGaD
Temsirolimus—MTOR—Adaptive Immune System—AKT1—malignant glioma	3.03e-05	6.3e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CAT—malignant glioma	3.03e-05	6.3e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Disease—AKT1—malignant glioma	3.01e-05	6.27e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTGS1—malignant glioma	2.99e-05	6.22e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—EGFR—malignant glioma	2.98e-05	6.19e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP2B6—malignant glioma	2.98e-05	6.19e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—BCHE—malignant glioma	2.95e-05	6.14e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PTEN—malignant glioma	2.94e-05	6.12e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PIK3CG—malignant glioma	2.94e-05	6.11e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—BRAF—malignant glioma	2.92e-05	6.08e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—SLC5A5—malignant glioma	2.91e-05	6.06e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—NCOR1—malignant glioma	2.86e-05	5.95e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—STAT3—malignant glioma	2.85e-05	5.93e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AKT2—malignant glioma	2.85e-05	5.92e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PPARG—malignant glioma	2.83e-05	5.89e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—KRAS—malignant glioma	2.81e-05	5.85e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—BCHE—malignant glioma	2.78e-05	5.78e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—SLC5A5—malignant glioma	2.75e-05	5.71e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PIK3CD—malignant glioma	2.73e-05	5.69e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—IDH1—malignant glioma	2.72e-05	5.66e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Transmembrane transport of small molecules—RAF1—malignant glioma	2.68e-05	5.58e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SPHK1—malignant glioma	2.63e-05	5.48e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—STAT3—malignant glioma	2.63e-05	5.47e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—FGF2—malignant glioma	2.62e-05	5.45e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—EGFR—malignant glioma	2.59e-05	5.39e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—PIK3CA—malignant glioma	2.58e-05	5.37e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PIK3CD—malignant glioma	2.58e-05	5.37e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CYP2C18—malignant glioma	2.58e-05	5.37e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—TP53—malignant glioma	2.5e-05	5.2e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MDM2—malignant glioma	2.45e-05	5.1e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—KRAS—malignant glioma	2.45e-05	5.09e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—MYC—malignant glioma	2.44e-05	5.08e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—RAF1—malignant glioma	2.44e-05	5.08e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—ERBB2—malignant glioma	2.42e-05	5.02e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—EGFR—malignant glioma	2.39e-05	4.97e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PIK3CB—malignant glioma	2.38e-05	4.96e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—GSTP1—malignant glioma	2.35e-05	4.88e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—CAV1—malignant glioma	2.33e-05	4.85e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CXCL8—malignant glioma	2.29e-05	4.76e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CAT—malignant glioma	2.28e-05	4.75e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—KRAS—malignant glioma	2.26e-05	4.7e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PIK3CB—malignant glioma	2.25e-05	4.68e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—PIK3CA—malignant glioma	2.25e-05	4.67e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTGS2—malignant glioma	2.23e-05	4.64e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—GSTP1—malignant glioma	2.21e-05	4.6e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—CASP3—malignant glioma	2.19e-05	4.56e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—IL2—malignant glioma	2.19e-05	4.55e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—NCOR1—malignant glioma	2.16e-05	4.49e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CAT—malignant glioma	2.15e-05	4.48e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PIK3CG—malignant glioma	2.12e-05	4.41e-05	CbGpPWpGaD
Temsirolimus—FKBP1A—Signaling Pathways—AKT1—malignant glioma	2.11e-05	4.39e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTT1—malignant glioma	2.09e-05	4.34e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—PIK3CA—malignant glioma	2.07e-05	4.32e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MMP9—malignant glioma	2.07e-05	4.31e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PTEN—malignant glioma	2.06e-05	4.28e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PPARG—malignant glioma	2.05e-05	4.26e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—NCOR1—malignant glioma	2.03e-05	4.23e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTGS1—malignant glioma	1.95e-05	4.07e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PTEN—malignant glioma	1.94e-05	4.04e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PIK3CD—malignant glioma	1.87e-05	3.88e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—VEGFA—malignant glioma	1.86e-05	3.87e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—STAT3—malignant glioma	1.84e-05	3.83e-05	CbGpPWpGaD
Temsirolimus—MTOR—Immune System—AKT1—malignant glioma	1.84e-05	3.82e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—BCHE—malignant glioma	1.82e-05	3.78e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—SLC5A5—malignant glioma	1.8e-05	3.73e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—CAV1—malignant glioma	1.76e-05	3.66e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—MYC—malignant glioma	1.71e-05	3.56e-05	CbGpPWpGaD
Temsirolimus—MTOR—Disease—AKT1—malignant glioma	1.7e-05	3.53e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—EGFR—malignant glioma	1.67e-05	3.48e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—CAV1—malignant glioma	1.66e-05	3.45e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PIK3CB—malignant glioma	1.63e-05	3.38e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTGS2—malignant glioma	1.61e-05	3.35e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PIK3CG—malignant glioma	1.6e-05	3.33e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—KRAS—malignant glioma	1.58e-05	3.29e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PPARG—malignant glioma	1.55e-05	3.22e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PIK3CG—malignant glioma	1.51e-05	3.14e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PPARG—malignant glioma	1.46e-05	3.03e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—PIK3CA—malignant glioma	1.45e-05	3.02e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—GSTP1—malignant glioma	1.45e-05	3.01e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PIK3CD—malignant glioma	1.41e-05	2.93e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CAT—malignant glioma	1.41e-05	2.93e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—TP53—malignant glioma	1.41e-05	2.92e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PTEN—malignant glioma	1.41e-05	2.92e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—PIK3CA—malignant glioma	1.37e-05	2.85e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—NCOR1—malignant glioma	1.33e-05	2.76e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PIK3CD—malignant glioma	1.33e-05	2.76e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PIK3CB—malignant glioma	1.23e-05	2.55e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTGS2—malignant glioma	1.22e-05	2.53e-05	CbGpPWpGaD
Temsirolimus—MTOR—Signaling Pathways—AKT1—malignant glioma	1.19e-05	2.47e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PIK3CB—malignant glioma	1.16e-05	2.41e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTGS2—malignant glioma	1.15e-05	2.38e-05	CbGpPWpGaD
Temsirolimus—CYP3A7—Metabolism—AKT1—malignant glioma	1.12e-05	2.33e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—CAV1—malignant glioma	1.08e-05	2.25e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PTEN—malignant glioma	1.06e-05	2.21e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PTEN—malignant glioma	9.99e-06	2.08e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—PIK3CA—malignant glioma	9.91e-06	2.06e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PIK3CG—malignant glioma	9.87e-06	2.05e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PPARG—malignant glioma	9.52e-06	1.98e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PIK3CD—malignant glioma	8.67e-06	1.8e-05	CbGpPWpGaD
Temsirolimus—CYP3A5—Metabolism—AKT1—malignant glioma	8.1e-06	1.68e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PIK3CB—malignant glioma	7.56e-06	1.57e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTGS2—malignant glioma	7.49e-06	1.56e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—PIK3CA—malignant glioma	7.48e-06	1.56e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—PIK3CA—malignant glioma	7.05e-06	1.47e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PTEN—malignant glioma	6.53e-06	1.36e-05	CbGpPWpGaD
Temsirolimus—ABCB1—Metabolism—AKT1—malignant glioma	6.11e-06	1.27e-05	CbGpPWpGaD
Temsirolimus—CYP2D6—Metabolism—AKT1—malignant glioma	5.76e-06	1.2e-05	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—PIK3CA—malignant glioma	4.61e-06	9.59e-06	CbGpPWpGaD
Temsirolimus—CYP3A4—Metabolism—AKT1—malignant glioma	3.77e-06	7.83e-06	CbGpPWpGaD
